Source: International Journal of Cancer. Unidade: FM
Assunto: ONCOLOGIA
ABNT
VEIGA, S S et al. Glycosylation of 'BETA'-1 integrins in b16-f10 mouse melanoma cells as determinant of differential binding and acquisition of biological activity. International Journal of Cancer, v. 61, n. 3 , p. 420-4, 1995Tradução . . Disponível em: https://doi.org/10.1002/ijc.2910610324. Acesso em: 06 nov. 2024.APA
Veiga, S. S., Chammas, R., Cella, N., & Brentani, R. R. (1995). Glycosylation of 'BETA'-1 integrins in b16-f10 mouse melanoma cells as determinant of differential binding and acquisition of biological activity. International Journal of Cancer, 61( 3 ), 420-4. doi:10.1002/ijc.2910610324NLM
Veiga SS, Chammas R, Cella N, Brentani RR. Glycosylation of 'BETA'-1 integrins in b16-f10 mouse melanoma cells as determinant of differential binding and acquisition of biological activity [Internet]. International Journal of Cancer. 1995 ;61( 3 ): 420-4.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/ijc.2910610324Vancouver
Veiga SS, Chammas R, Cella N, Brentani RR. Glycosylation of 'BETA'-1 integrins in b16-f10 mouse melanoma cells as determinant of differential binding and acquisition of biological activity [Internet]. International Journal of Cancer. 1995 ;61( 3 ): 420-4.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1002/ijc.2910610324